Biotech Gainers: Growing Stock Report Adds Rexahn Pharmaceuticals, Inc. (NYSE:RNN), Keryx Biopharmaceuticals Inc. (Nasdaq:KERX) and Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) to Their Biotech Watch List

New York, NY -- (SBWIRE) -- 01/31/2013 -- Biotech Gainers: Growing Stock Report adds Rexahn Pharmaceuticals, Inc. (NYSE:RNN), Keryx Biopharmaceuticals Inc. (Nasdaq:KERX) and Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) to their Biotech Watch List.

Rexahn Pharmaceuticals, Inc. (NYSE:RNN) - a development stage biopharmaceutical company that engages in the discovery and development of treatments for cancer and other disorders of central nervous system is currently up (+1.46%) on higher than normal volume. With this stock gaining and trading with high volume, it prompted Growing Stock Report to add RNN to their Biotech Gainers watch list.

Click Here to find out what other Investors are saying about Rexahn Pharmaceuticals, Inc.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) - a clinical-stage biopharmaceutical company, engages in discovering, developing, and commercializing oral drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases is up (+5.68%). Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) is still up big from it's 52-week, up(+408.24%) from its 52-week low which prompted Growing Stock Report to add ARNA to their Biotech Gainers watch list.

Click Here to find out what other Investors are saying about Arena Pharmaceuticals, Inc.

Keryx Biopharmaceuticals Inc. (Nasdaq:KERX)- a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States is currently up (+7.54%) today, but was up much higher in early tradign. Keryx Biopharmaceuticals Inc. (Nasdaq:KERX) yesterday announced the pricing of its previously announced underwritten public offering of common stock consisting of 8,234,000 shares at $8.49 per share.

Click Here to find out what other Investors are saying about Keryx Biopharmaceuticals Inc.

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure: GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com